<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Comparison of clinical data, viral etiologies and outcome between patients with upper and lower respiratory tract infection.</p>
 </caption>
 <alt-text id="alttext0035">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2"/>
    <th rowspan="2">URTI
     <xref rid="tbl3fna" ref-type="table-fn">a</xref>
    </th>
    <th rowspan="2">LRTI
     <xref rid="tbl3fnb" ref-type="table-fn">b</xref>
    </th>
    <th colspan="2">Univariate Analysis
     <hr/>
    </th>
    <th colspan="2">Multivariable Analysis
     <xref rid="tbl3fnc" ref-type="table-fn">c</xref>
     <hr/>
    </th>
   </tr>
   <tr>
    <th>OR (95% CI)</th>
    <th>p-value</th>
    <th>aOR (95% CI)</th>
    <th>p-value</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Number, n</td>
    <td>58</td>
    <td>167</td>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Gender (Male: female)</td>
    <td>55.2%</td>
    <td>62.3%</td>
    <td>1.341 (0.73–2.45)</td>
    <td>0.341</td>
    <td>1.721 (0.83–3.53)</td>
    <td>0.140</td>
   </tr>
   <tr>
    <td>
     <bold>Age (year)</bold>
    </td>
    <td>2.73 ± 2.79</td>
    <td>2.36 ± 2.53</td>
    <td/>
    <td>0.357</td>
    <td>0.987 (0.85–1.13)</td>
    <td>0.860</td>
   </tr>
   <tr>
    <td>≤2 y/o (%)</td>
    <td>56.9%</td>
    <td>58.1%</td>
    <td>1.050 (0.57–1.92)</td>
    <td>0.875</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>&gt;2 y/o ∼ ≤ 5 y/o (%)</td>
    <td>32.8%</td>
    <td>35.3%</td>
    <td>1.121 (0.59–2.11)</td>
    <td>0.723</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>&gt;5 y/o (%)</td>
    <td>10.3%</td>
    <td>6.6%</td>
    <td>0.611 (0.21–1.73)</td>
    <td>0.351</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">
     <bold>Pathogen</bold>
    </td>
   </tr>
   <tr>
    <td>Multiple viral infections (%)</td>
    <td>15.5%</td>
    <td>30.5%</td>
    <td>2.394 (1.09–5.23)</td>
    <td>0.026*</td>
    <td>2.996 (1.17–7.65)</td>
    <td>0.022*</td>
   </tr>
   <tr>
    <td>HAdV (%)</td>
    <td>10.3%</td>
    <td>7.8%</td>
    <td>0.732 (0.26–2.02)</td>
    <td>0.546</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Flu A (%)</td>
    <td>8.6%</td>
    <td>1.8%</td>
    <td>0.194 (0.04–0.83)</td>
    <td>0.016*</td>
    <td>0.189 (0.03–1.08)</td>
    <td>0.061</td>
   </tr>
   <tr>
    <td>Flu B (%)</td>
    <td>5.2%</td>
    <td>1.2%</td>
    <td>0.222 (0.03–1.36)</td>
    <td>0.077</td>
    <td>0.060 (0.006–0.57)</td>
    <td>0.015*</td>
   </tr>
   <tr>
    <td>PIV (%)</td>
    <td>32.8%</td>
    <td>19.8%</td>
    <td>0.505 (0.25–0.98)</td>
    <td>0.043*</td>
    <td>0.620 (0.27–1.41)</td>
    <td>0.258</td>
   </tr>
   <tr>
    <td>PIV1 (%)</td>
    <td>15.5%</td>
    <td>6.6%</td>
    <td>0.384 (0.15–0.98)</td>
    <td>0.040*</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>PIV3 (%)</td>
    <td>17.2%</td>
    <td>10.8%</td>
    <td>0.580 (0.25–1.34)</td>
    <td>0.199</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>PIV4 (%)</td>
    <td>1.7%</td>
    <td>1.8%</td>
    <td>1.043 (0.10–10.2)</td>
    <td>0.971</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>hMPV (%)</td>
    <td>3.4%</td>
    <td>6.0%</td>
    <td>1.783 (0.37–8.39)</td>
    <td>0.458</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>HCoV (%)</td>
    <td>12.1%</td>
    <td>4.2%</td>
    <td>0.319 (0.10–0.95)</td>
    <td>0.032*</td>
    <td>0.255 (0.06–0.96)</td>
    <td>0.044*</td>
   </tr>
   <tr>
    <td>RSV (%)</td>
    <td>8.6%</td>
    <td>41.3%</td>
    <td>7.463 (2.83–19.6)</td>
    <td>&lt;0.001*</td>
    <td>6.477 (2.17–19.27)</td>
    <td>0.001*</td>
   </tr>
   <tr>
    <td>HRV (%)</td>
    <td>34.5%</td>
    <td>41.9%</td>
    <td>1.371 (0.73–2.55)</td>
    <td>0.319</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>EV (%)</td>
    <td>1.7%</td>
    <td>0.0%</td>
    <td/>
    <td>0.089</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>HBoV (%)</td>
    <td>5.2%</td>
    <td>8.4%</td>
    <td>1.678 (0.46–6.06)</td>
    <td>0.425</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">
     <bold>Symptoms</bold>
    </td>
   </tr>
   <tr>
    <td>Fever duration (d)</td>
    <td>3.93 ± 3.41</td>
    <td>3.89 ± 2.72</td>
    <td/>
    <td>0.931</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td colspan="7">
     <bold>Lab data</bold>
    </td>
   </tr>
   <tr>
    <td>WBC (/ul)</td>
    <td>11,307 ± 5738</td>
    <td>10,743 ± 4856</td>
    <td/>
    <td>0.469</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>CRP (mg/dl)</td>
    <td>2.03 ± 2.87</td>
    <td>1.97 ± 3.40</td>
    <td/>
    <td>0.907</td>
    <td>0.985 (0.87–1.10)</td>
    <td>0.798</td>
   </tr>
   <tr>
    <td colspan="7">
     <bold>Outcome</bold>
    </td>
   </tr>
   <tr>
    <td>Antibiotic treatment duration (d)</td>
    <td>1.52 ± 2.28</td>
    <td>2.53 ± 3.56</td>
    <td/>
    <td>0.044*</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>ICU admission (%)</td>
    <td>5.2%</td>
    <td>18.6%</td>
    <td>4.179 (1.22–14.2)</td>
    <td>0.014*</td>
    <td>3.308 (0.82–13.28)</td>
    <td>0.092</td>
   </tr>
   <tr>
    <td>Hospitalization duration (d)</td>
    <td>3.53 ± 1.76</td>
    <td>5.08 ± 4.36</td>
    <td/>
    <td>0.009*</td>
    <td>1.306 (1.06–1.60)</td>
    <td>0.011*</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tspara0050">
   <p>Mean ± Standard deviation; OR = Odds ratio; aOR = adjusted Odds ratio; CI = confidence interval; d = day; URTI = upper respiratory tract infection; LRTI = lower respiratory tract infection; WBC = white blood cell; CRP = C-reactive protein; ICU = intensive care unit.</p>
  </fn>
  <fn id="tspara0055">
   <p>*p &lt; 0.05.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl3fna">
   <label>a</label>
   <p id="ntpara0025">We excluded patients with AOM, acute sinusitis, herpangina and evidence of bacterial infection.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl3fnb">
   <label>b</label>
   <p id="ntpara0030">We excluded patients with evidence of bacterial infection.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl3fnc">
   <label>c</label>
   <p id="ntpara0035">Adjusted with comorbidity (congenital heart disease, chronic respiratory disease, chronic neurological disease, prematurity, malignancy).</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
